Goldman Sachs’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $145M | Sell |
187,600
-8,600
| -4% | -$6.58M | 0.02% | 839 |
|
|
2025
Q4 | $151M | Sell |
196,200
-67,000
| -25% | -$45.5M | 0.02% | 758 |
|
|
2025
Q3 | $148M | Sell |
263,200
-6,200
| -2% | -$3.51M | 0.02% | 735 |
|
|
2025
Q2 | $141M | Sell |
269,400
-12,200
| -4% | -$6.81M | 0.02% | 715 |
|
|
2025
Q1 | $179M | Sell |
281,600
-78,800
| -22% | -$54.2M | 0.03% | 551 |
|
|
2024
Q4 | $257M | Buy |
360,400
+72,000
| +25% | +$60.4M | 0.04% | 420 |
|
|
2024
Q3 | $303M | Buy |
288,400
+30,900
| +12% | +$34.4M | 0.05% | 376 |
|
|
2024
Q2 | $271M | Buy |
257,500
+216,500
| +528% | +$210M | 0.05% | 419 |
|
|
2024
Q1 | $39.5M | Sell |
41,000
-1,900
| -4% | -$1.81M | 0.01% | 1315 |
|
|
2023
Q4 | $37.7M | Buy |
42,900
+18,200
| +74% | +$15M | 0.01% | 1383 |
|
|
2023
Q3 | $20.3M | Sell |
24,700
-17,000
| -41% | -$13.4M | ﹤0.01% | 1785 |
|
|
2023
Q2 | $30M | Sell |
41,700
-17,000
| -29% | -$13.1M | 0.01% | 1505 |
|
|
2023
Q1 | $48.2M | Sell |
58,700
-42,100
| -42% | -$31.8M | 0.01% | 1092 |
|
|
2022
Q4 | $72.7M | Buy |
100,800
+89,800
| +816% | +$66.3M | 0.02% | 898 |
|
|
2022
Q3 | $7.58M | Buy |
11,000
+4,200
| +62% | +$2.64M | ﹤0.01% | 2769 |
|
|
2022
Q2 | $4.02M | Sell |
6,800
-11,900
| -64% | -$7.74M | ﹤0.01% | 3363 |
|
|
2022
Q1 | $13.1M | Buy |
18,700
+12,400
| +197% | +$7.84M | ﹤0.01% | 2425 |
|
|
2021
Q4 | $3.98M | Buy |
6,300
+2,600
| +70% | +$1.6M | ﹤0.01% | 3634 |
|
|
2021
Q3 | $2.24M | Buy |
+3,700
| New | +$2.3M | ﹤0.01% | 4092 |
|
|
2021
Q1 | – | Sell |
-21,000
| Closed | -$10.1M | – | 6300 |
|
|
2020
Q4 | $10.1M | Buy |
21,000
+11,800
| +128% | +$6.37M | ﹤0.01% | 2454 |
|
|
2020
Q3 | $5.15M | Buy |
9,200
+8,100
| +736% | +$4.91M | ﹤0.01% | 2871 |
|
|
2020
Q2 | $686K | Sell |
1,100
-9,600
| -90% | -$5.45M | ﹤0.01% | 4201 |
|
|
2020
Q1 | $5.22M | Buy |
10,700
+4,500
| +73% | +$1.86M | ﹤0.01% | 2599 |
|
|
2019
Q4 | $2.33M | Buy |
+6,200
| New | +$2.09M | ﹤0.01% | 3534 |
|
|
2019
Q3 | – | Sell |
-17,500
| Closed | -$5.48M | – | 5345 |
|
|
2019
Q2 | $5.48M | Buy |
17,500
+400
| +2% | +$133K | ﹤0.01% | 2785 |
|
|
2019
Q1 | $7.02M | Buy |
17,100
+10,400
| +155% | +$4.28M | ﹤0.01% | 2714 |
|
|
2018
Q4 | $2.5M | Sell |
6,700
-3,800
| -36% | -$1.39M | ﹤0.01% | 3394 |
|
|
2018
Q3 | $4.24M | Sell |
10,500
-5,900
| -36% | -$2.25M | ﹤0.01% | 3106 |
|
|
2018
Q2 | $5.66M | Sell |
16,400
-6,500
| -28% | -$2.03M | ﹤0.01% | 2876 |
|
|
2018
Q1 | $7.89M | Sell |
22,900
-61,200
| -73% | -$21.3M | ﹤0.01% | 2536 |
|
|
2017
Q4 | $31.6M | Sell |
84,100
-14,000
| -14% | -$5.67M | 0.01% | 1608 |
|
|
2017
Q3 | $43.9M | Sell |
98,100
-1,500
| -2% | -$714K | 0.01% | 1385 |
|
|
2017
Q2 | $48.9M | Sell |
99,600
-9,700
| -9% | -$4.24M | 0.01% | 1254 |
|
|
2017
Q1 | $42.4M | Sell |
109,300
-189,400
| -63% | -$70.2M | 0.01% | 1338 |
|
|
2016
Q4 | $110M | Buy |
298,700
+169,400
| +131% | +$64.4M | 0.03% | 715 |
|
|
2016
Q3 | $52M | Buy |
129,300
+4,100
| +3% | +$1.64M | 0.02% | 1176 |
|
|
2016
Q2 | $43.7M | Buy |
125,200
+2,700
| +2% | +$1.04M | 0.01% | 1215 |
|
|
2016
Q1 | $44.2M | Buy |
122,500
+56,900
| +87% | +$23.4M | 0.01% | 1166 |
|
|
2015
Q4 | $35.6M | Buy |
65,600
+15,100
| +30% | +$8.18M | 0.01% | 1360 |
|
|
2015
Q3 | $23.5M | Buy |
50,500
+5,400
| +12% | +$2.9M | 0.01% | 1600 |
|
|
2015
Q2 | $23M | Buy |
45,100
+3,200
| +8% | +$1.56M | 0.01% | 1687 |
|
|
2015
Q1 | $18.9M | Sell |
41,900
-65,300
| -61% | -$27.7M | 0.01% | 1795 |
|
|
2014
Q4 | $44M | Buy |
107,200
+76,200
| +246% | +$30M | 0.01% | 1210 |
|
|
2014
Q3 | $11.2M | Sell |
31,000
-2,800
| -8% | -$938K | ﹤0.01% | 2271 |
|
|
2014
Q2 | $9.55M | Sell |
33,800
-18,700
| -36% | -$5.54M | ﹤0.01% | 2404 |
|
|
2014
Q1 | $15.8M | Sell |
52,500
-18,900
| -26% | -$5.82M | 0.01% | 1967 |
|
|
2013
Q4 | $19.7M | Sell |
71,400
-11,400
| -14% | -$3.28M | 0.01% | 1753 |
|
|
2013
Q3 | $25.9M | Buy |
82,800
+26,900
| +48% | +$7.08M | 0.01% | 1404 |
|
|
2013
Q2 | $12.6M | Buy |
+55,900
| New | +$13M | ﹤0.01% | 1897 |
|
Other funds holding REGN
VCM
N
Goldman Sachs's REGN Position: Q1 2026 in Review
Goldman Sachs increased its Regeneron Pharmaceuticals (REGN) stake by 19% in Q1 2026, buying an estimated $156M and bringing the position to 1,300,558 shares worth $1B. The position accounts for 0.12% of the portfolio, ranked #168.
Goldman Sachs first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Goldman Sachs held 1,300,558 shares of Regeneron Pharmaceuticals worth $1B as of Q1 2026.
- Goldman Sachs bought 203,231 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $156M.
- Regeneron Pharmaceuticals made up 0.12% of Goldman Sachs's portfolio in Q1 2026, its #168 holding.
- Goldman Sachs first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.